These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1966495)

  • 1. [Pathology of the cytoskeleton in Alzheimer's disease and disorders related to this disease].
    Seitelberg F; Lassmann H
    Gac Med Mex; 1990; 126(5):367-73. PubMed ID: 1966495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoskeleton pathology in Alzheimer's disease and related disorders.
    Seitelberger F; Lassmann H; Bancher C
    J Neural Transm Suppl; 1991; 33():27-33. PubMed ID: 1753248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and mallory bodies in alcoholic liver disease.
    Lowe J; Blanchard A; Morrell K; Lennox G; Reynolds L; Billett M; Landon M; Mayer RJ
    J Pathol; 1988 May; 155(1):9-15. PubMed ID: 2837558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation.
    Shi J; Shaw CL; Du Plessis D; Richardson AM; Bailey KL; Julien C; Stopford C; Thompson J; Varma A; Craufurd D; Tian J; Pickering-Brown S; Neary D; Snowden JS; Mann DM
    Acta Neuropathol; 2005 Nov; 110(5):501-12. PubMed ID: 16222525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The widespread alteration of neurites in Alzheimer's disease may be unrelated to amyloid deposition.
    Tabaton M; Mandybur TI; Perry G; Onorato M; Autilio-Gambetti L; Gambetti P
    Ann Neurol; 1989 Dec; 26(6):771-8. PubMed ID: 2557796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau antisera recognize neurofibrillary tangles in a range of neurodegenerative disorders.
    Joachim CL; Morris JH; Kosik KS; Selkoe DJ
    Ann Neurol; 1987 Oct; 22(4):514-20. PubMed ID: 2963585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New developments in the pathology of Parkinson's disease.
    Jellinger K
    Adv Neurol; 1990; 53():1-16. PubMed ID: 1978509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoskeletal immunohistochemistry of Alzheimer's disease.
    Ulrich J; Anderton BH; Brion JP; Euler M; Probst A
    J Neural Transm Suppl; 1987; 24():197-204. PubMed ID: 3479523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of neurofibrillary degeneration in Alzheimer's disease. An immunohistochemical study.
    Bondareff W; Wischik CM; Novak M; Amos WB; Klug A; Roth M
    Am J Pathol; 1990 Sep; 137(3):711-23. PubMed ID: 2169192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alz-50, ubiquitin and tau immunoreactivity of neurofibrillary tangles, Pick bodies and Lewy bodies.
    Love S; Saitoh T; Quijada S; Cole GM; Terry RD
    J Neuropathol Exp Neurol; 1988 Jul; 47(4):393-405. PubMed ID: 2838588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of epitopes shared by Hirano bodies and neurofilament proteins in normal and Alzheimer's disease hippocampus.
    Schmidt ML; Lee VM; Trojanowski JQ
    Lab Invest; 1989 Apr; 60(4):513-22. PubMed ID: 2468822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurofibrillary tangles and the neuronal cytoskeleton.
    Anderton BH; Brion JP; Flament-Durand J; Haugh MC; Kahn J; Miller CC; Probst A; Ulrich J
    J Neural Transm Suppl; 1987; 24():191-6. PubMed ID: 3119774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alz 50 recognizes abnormal filaments in Alzheimer's disease and progressive supranuclear palsy.
    Tabaton M; Whitehouse PJ; Perry G; Davies P; Autilio-Gambetti L; Gambetti P
    Ann Neurol; 1988 Sep; 24(3):407-13. PubMed ID: 3067653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermediate filaments and ubiquitin: a new thread in the understanding of chronic neurodegenerative diseases.
    Mayer RJ; Lowe J; Lennox G; Doherty F; Landon M
    Prog Clin Biol Res; 1989; 317():809-18. PubMed ID: 2557642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of antigenic determinants that distinguish neurofibrillary tangles in progressive supranuclear palsy and Alzheimer's disease.
    Schmidt ML; Lee VM; Hurtig H; Trojanowski JQ
    Lab Invest; 1988 Oct; 59(4):460-6. PubMed ID: 2459498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Alzheimer's disease: lesions and their progression].
    Duyckaerts C; Colle MA; Delatour B; Hauw JJ
    Rev Neurol (Paris); 1999; 155 Suppl 4():S17-27. PubMed ID: 10637934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
    van de Nes JA; Nafe R; Schlote W
    Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau protein immunoreactivity in dementia of the Alzheimer type: II. Electron microscopy and pathogenetic implications. Effects of fixation on the morphology of the Alzheimer's abnormal filaments.
    Papasozomenos SC
    Lab Invest; 1989 Mar; 60(3):375-89. PubMed ID: 2494388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of neuritic cytoarchitecture in Alzheimer disease.
    Onorato M; Mulvihill P; Connolly J; Galloway P; Whitehouse P; Perry G
    Prog Clin Biol Res; 1989; 317():781-9. PubMed ID: 2690122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer disease pathology in amyotrophic lateral sclerosis.
    Hamilton RL; Bowser R
    Acta Neuropathol; 2004 Jun; 107(6):515-22. PubMed ID: 15024584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.